Table 2 Diagnosis accuracy assessment of ceramides in predicting ACS.
From: Cer(d18:1/16:0) as a biomarkers for acute coronary syndrome in Chinese populations
AUC | Accuracy (%) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|---|---|
Cer(d18:1/14:0) | 0.551 (0.516–0.586) | 48.9 | 44.0 | 66.6 | 80.1 | 27.8 |
Cer(d18:1/16:0) | 0.678 (0.645–0.710) | 61.3 | 58.7 | 69.3 | 85.4 | 35.3 |
Cer(d18:1/18:0) | 0.565 (0.530–0.600) | 46.5 | 38.4 | 71.5 | 80.5 | 27.4 |
Cer(d18:1/20:0) | 0.545 (0.509–0.580) | 39.7 | 25.6 | 83.1 | 82.3 | 26.6 |
Cer(d18:1/22:0) | 0.542 (0.506–0.577) | 44.5 | 32.8 | 75.5 | 80.3 | 26.7 |
Cer(d18:1/24:0) | 0.547 (0.512–0.583) | 51.8 | 49.3 | 59.8 | 79.0 | 27.7 |
Cer(d18:1/24:1) | 0.524 (0.489–0.559) | 51.4 | 49.3 | 58.0 | 78.2 | 27.1 |
